本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

泰坦制药

3.85
+0.17004.62%
成交量:2.36万
成交额:8.84万
市值:351.98万
市盈率:-0.74
高:3.90
开:3.80
低:3.65
收:3.68
数据加载中...
2022/07/11

重要事件披露

8-K - Current report
2022/07/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/05

重要事件披露

8-K - Current report
2022/06/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/02

重要事件披露

8-K - Current report
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/06

重要事件披露

8-K - Current report
2022/04/25

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/04/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/03/31

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/31

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/03/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/02/03

重要事件披露

8-K - Current report
2022/01/24

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/03

重要事件披露

8-K - Current report
2021/12/29

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report